Manifold Bio Demonstrates Million-Scale Experimental Validation of AI-Driven Protein Binder Design with NVIDIA

The company showcased its ability to rapidly design and validate millions of protein binders using AI and NVIDIA technology.

Mar. 16, 2026 at 10:19pm

Got story updates? Submit your updates here. ›

Manifold Bio, a Boston-based biotechnology company, has demonstrated the ability to rapidly design and validate millions of protein binders using artificial intelligence (AI) and NVIDIA technology. The company showcased this capability in a recent announcement, highlighting its advancements in AI-driven protein engineering.

Why it matters

Manifold Bio's achievement represents a significant step forward in the field of protein engineering, which is crucial for the development of new therapies and biotechnological applications. The ability to rapidly design and validate large numbers of protein binders using AI could lead to faster and more efficient drug discovery and development processes.

The details

Manifold Bio utilized NVIDIA's GPU-accelerated computing platform to power its AI-driven protein binder design process. The company was able to design and experimentally validate over 1 million unique protein binders, demonstrating the scalability and efficiency of its approach. This breakthrough could have far-reaching implications for the biotechnology industry, as it enables researchers to explore a much larger chemical space and identify promising candidates more quickly.

  • Manifold Bio announced its achievement on March 16, 2026.

The players

Manifold Bio

A Boston-based biotechnology company that specializes in AI-driven protein engineering.

NVIDIA

A technology company that develops GPU-accelerated computing platforms, which were used by Manifold Bio in its protein binder design process.

Got photos? Submit your photos here. ›

What’s next

Manifold Bio plans to continue advancing its AI-driven protein engineering capabilities and exploring new applications in the biotechnology and pharmaceutical industries.

The takeaway

Manifold Bio's ability to rapidly design and validate millions of protein binders using AI and NVIDIA technology represents a significant breakthrough in the field of protein engineering, with the potential to accelerate drug discovery and development processes.